Whalesbook
Analyst Downgrade Signals Caution for PCBL Chemical
Prabhudas Lilladher has revised its stance on PCBL Chemical, moving the stock to a 'HOLD' rating and establishing a price target of Rs 302. This adjustment, based on an 18x multiple of December 2027 estimated earnings per share, signals a more cautious outlook for the chemical manufacturer. The firm's analysis points to significant headwinds from increased competition due to cheaper imports and a persistently weak demand environment.
Q3FY26 Performance Plummets
PCBL Chemical's consolidated revenue for the third quarter of fiscal year 2026 registered Rs 18.5 billion, marking a substantial 15% decrease sequentially and an 8% drop year-on-year. This downturn was primarily driven by a 13% quarter-on-quarter and 2% year-on-year decline in carbon black volumes. Furthermore, the company experienced a sharp fall in realization prices to Rs 104. The adverse impact of lower operating leverage resulted in a significant reduction in EBITDA per tonne, falling to Rs 13,855 from Rs 19,868 in the same period last fiscal year.
Segmental Weakness and Outlook
The pressure on realizations is anticipated to persist in the near term, exacerbated by the ongoing influx of cheaper imported goods and subdued market demand. The company's power segment also saw a considerable contraction, with revenue declining 27% quarter-on-quarter to Rs 779 million, largely attributed to reduced carbon black production. Similarly, the Aquapharm (Chemicals) segment reported a 17% sequential drop in topline amidst geopolitical tensions affecting supply chains. Looking ahead, Prabhudas Lilladher forecasts carbon black volumes to grow by 2% in FY26 and 11% in FY27, supported by new capacity additions. However, EBITDA per tonne is expected to remain subdued, hovering around Rs 15,545 in FY26 and Rs 17,100 in FY27, reflecting continued pricing pressures. Margins in the Aquapharm segment are also projected to stay under pressure, despite management guidance of 20% volume growth in FY27. The stock currently trades at 16 times its estimated FY28 earnings per share.